Analysis of gene expression profiles in rat hippocampus following treatment with nicotine and an α7 nAChR selective agonist

Neuroscience Research

Volumn 60, Issue 3, 2008, Pages 266-274

  Waring, Jeffrey F ^a   Abel, Stephen ^a   Li, Jinhe ^a   Bitner, R Scott ^a   Nikkel, Arthur L ^a   Blomme, Eric A ^a   Anderson, David J ^a   Gopalakrishnan, Murali ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

Alzheimer's disease; Gene expression; Microarray; Nicotine; Nicotinic receptor; Transcription

Indexed keywords

BUNGAROTOXIN RECEPTOR; NICOTINE; NICOTINIC RECEPTOR; PNU 282987; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; COGNITION; CONTROLLED STUDY; GENE EXPRESSION; GENETIC ANALYSIS; HIPPOCAMPUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; UNINDEXED SEQUENCE;

EID: 40649099564     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2007.11.008     Document Type: Article

References (52)

1. C.G. Almeida D. Tampellini R.H. Takahashi P. Greengard M.T. Lin E.M. Snyder G.K. Gouras Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses Neurobiol. Dis. 20 2 2005 187 198
2. N. Belluardo P.A. Olsson G. Mudo W.H. Sommer G. Amato K. Fuxe Transcription factor gene expression profiling after acute intermittent nicotine treatment in the rat cerebral cortex Neuroscience 133 3 2005 787 796
3. D.K. Berg W.G. Conroy Nicotinic alpha 7 receptors: synaptic options and downstream signaling in neurons J Neurobiol. 53 4 2002 512 523
4. R. Bitner D. Anderson W. Bunnelle C. Briggs J. Buccafusco P. Curzon M. Decker H. Gronlein E. Gubbins M. Haakerud J. Frost K. Kohlhaas J. Li J. Malysz M. Meyer R. Radek H. Robb K. Marsh J. Sullivan M. Gopalakrishnan Broad spectrum efficacy in cognition by alpha7 neuronal nicotinic receptor activation of the MAP kinase pathway Int. J. Neuropsychopharmacol. 9 Suppl. 1 2006 S122
5. A.L. Bodnar L.A. Cortes-Burgos K.K. Cook D.M. Dinh V.E. Groppi M. Hajos N.R. Higdon W.E. Hoffmann R.S. Hurst J.K. Myers B.N. Rogers T.M. Wall M.L. Wolfe E. Wong Discovery and structure–activity relationship of quinuclidine benzamides as agonists of alpha7 nicotinic acetylcholine receptors J. Med. Chem. 48 4 2005 905 908
6. F.G. Boess J. De Vry C. Erb T. Flessner M. Hendrix J. Luithle C. Methfessel B. Riedl K. Schnizler F.J. van der Staay M. van Kampen W.B. Wiese G. Koenig The novel alpha7 nicotinic acetylcholine receptor agonist N -[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide improves working and recognition memory in rodents J. Pharmacol. Exp. Ther. 321 2 2007 716 725
7. J.J. Buccafusco S.R. Letchworth M. Bencherif P.M. Lippiello Long-lasting cognitive improvement with nicotinic receptor agonists: mechanisms of pharmacokinetic–pharmacodynamic discordance Trends Pharmacol. Sci. 26 7 2005 352 360
8. B.H. Chang S. Mukherji T.R. Soderling Characterization of a calmodulin kinase II inhibitor protein in brain Proc. Natl. Acad. Sci. U.S.A. 95 18 1998 10890 10895
9. Z.Z. Chong F. Li K. Maiese Group I metabotropic receptor neuroprotection requires Akt and its substrates that govern FOXO3a, Bim, and beta-catenin during oxidative stress Curr. Neurovasc. Res. 3 2 2006 107 117
10. S. Couturier D. Bertrand J.M. Matter M.C. Hernandez S. Bertrand N. Millar S. Valera T. Barkas M. Ballivet A neuronal nicotinic acetylcholine receptor subunit (alpha 7) is developmentally regulated and forms a homo-oligomeric channel blocked by alpha-BTX Neuron 5 6 1990 847 856
11. P. Curzon D.J. Anderson A.L. Nikkel G.B. Fox M. Gopalakrishnan M.W. Decker R.S. Bitner Antisense knockdown of the rat alpha7 nicotinic acetylcholine receptor produces spatial memory impairment Neurosci. Lett. 410 1 2006 15 19
12. F. Dajas-Bailador S. Wonnacott Nicotinic acetylcholine receptors and the regulation of neuronal signalling Trends Pharmacol. Sci. 25 6 2004 317 324
13. N. Delibas D.K. Doguc R. Sutcu E. Eroglu O. Gokalp Effect of nicotine on hippocampal nicotinic acetylcholine alpha7 receptor and NMDA receptor subunits 2A and 2B expression in young and old rats Int. J. Neurosci. 115 8 2005 1151 1163
14. T. Dunckley R.J. Lukas Nicotine modulates the expression of a diverse set of genes in the neuronal SH-SY5Y cell line J. Biol. Chem. 278 18 2003 15633 15640
15. T. Dunckley R.J. Lukas Nicotinic modulation of gene expression in SH-SY5Y neuroblastoma cells Brain Res. 1116 1 2006 39 49
16. C. Fernandes E. Hoyle E. Dempster L.C. Schalkwyk D.A. Collier Performance deficit of alpha7 nicotinic receptor knockout mice in a delayed matching-to-place task suggests a mild impairment of working/episodic-like memory Genes Brain Behav. 5 6 2006 433 440
17. J.L. Garrido J.A. Godoy A. Alvarez M. Bronfman N.C. Inestrosa Protein kinase C inhibits amyloid beta peptide neurotoxicity by acting on members of the Wnt pathway FASEB J. 16 14 2002 1982 1984
18. M. Gopalakrishnan J. Li E. Gubbins P. Puttfarcken A. Nikkel W. Bunnelle R.S. Bitner Activation of ERK-CREB and AKT/GSK3beta pathways via alpha-7 neuronal nicotinic receptors: potential for disease modification in Alzheimer's disease Abstracts of the 10th International Conference on Alzheimer's disease and related disorders Madrid, Spain, July 2006
19. C. Gotti F. Clementi Neuronal nicotinic receptors: from structure to pathology Prog. Neurobiol. 74 6 2004 363 396
20. C. Gotti M. Moretti I. Bohr I. Ziabreva S. Vailati R. Longhi L. Riganti A. Gaimarri I.G. McKeith R.H. Perry D. Aarsland J.P. Larsen E. Sher R. Beattie F. Clementi J.A. Court Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease Parkinson's disease and dementia with Lewy bodies by immunoprecipitation Neurobiol. Dis. 23 2 2006 481 489
21. N.W. Gray L. Fourgeaud B. Huang J. Chen H. Cao B.J. Oswald A. Hemar M.A. McNiven Dynamin 3 is a component of the postsynapse, where it interacts with mGluR5 and Homer Curr. Biol. 13 6 2003 510 515
22. M. Hajos R.S. Hurst W.E. Hoffmann M. Krause T.M. Wall N.R. Higdon V.E. Groppi The selective alpha7 nicotinic acetylcholine receptor agonist PNU-282987 [ N -[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide hydrochloride] enhances GABAergic synaptic activity in brain slices and restores auditory gating deficits in anesthetized rats J. Pharmacol. Exp. Ther. 312 3 2005 1213 1222
23. J.K. Kane Y. Hwang O. Konu S.E. Loughlin F.M. Leslie M.D. Li Regulation of Homer and group I metabotropic glutamate receptors by nicotine Eur. J. Neurosci. 21 5 2005 1145 1154
24. J.J. Keller A.B. Keller B.J. Bowers J.M. Wehner Performance of alpha7 nicotinic receptor null mutants is impaired in appetitive learning measured in a signaled nose poke task. Behav. Brain Res. 162 1 2005 143 152
25. J.R. Kim S.R. Lee H.J. Chung S. Kim S.H. Baek J.H. Kim Y.S. Kim Identification of amyloid beta-peptide responsive genes by cDNA microarray technology: involvement of RTP801 in amyloid beta-peptide toxicity Exp. Mol. Med. 35 5 2003 403 411
26. O. Konu X. Xu J.Z. Ma J. Kane J. Wang S.J. Shi M.D. Li Application of a customized pathway-focused microarray for gene expression profiling of cellular homeostasis upon exposure to nicotine in PC12 cells. Brain Res. Mol. Brain Res. 121 1–2 2004 102 113
27. F.M. Laferla K.N. Green S. Oddo Intracellular amyloid-beta in Alzheimer's disease Nat. Rev. Neurosci. 8 7 2007 499 509
28. P. Le Greves W. Huang Q. Zhou M. Thornwall F. Nyberg Acute effects of morphine on the expression of mRNAs for NMDA receptor subunits in the rat hippocampus, hypothalamus and spinal cord Eur. J. Pharmacol. 341 2–3 1998 161 164
29. E.D. Levin A.H. Rezvani Nicotinic treatment for cognitive dysfunction Curr. Drug. Targets CNS Neurol. Disord. 1 4 2002 423 431
30. M.D. Li J.K. Kane J. Wang J.Z. Ma Time-dependent changes in transcriptional profiles within five rat brain regions in response to nicotine treatment Brain Res. Mol. Brain Res. 132 2 2004 168 180
31. M.J. Liguori M.G. Anderson S. Bukofzer J. McKim J.F. Pregenzer J. Retief B.B. Spear J.F. Waring Microarray analysis in human hepatocytes suggests a mechanism for hepatotoxicity induced by trovafloxacin Hepatology 41 1 2005 177 186
32. M.F. Lise T.P. Wong A. Trinh R.M. Hines L. Liu R. Kang D.J. Hines J. Lu J.R. Goldenring Y.T. Wang A. El-Husseini Involvement of myosin Vb in glutamate receptor trafficking J. Biol. Chem. 281 6 2006 3669 3678
33. S.G. Matta D.J. Balfour N.L. Benowitz R.T. Boyd J.J. Buccafusco A.R. Caggiula C.R. Craig A.C. Collins M.I. Damaj E.C. Donny P.S. Gardiner S.R. Grady U. Heberlein S.S. Leonard E.D. Levin R.J. Lukas A. Markou M.J. Marks S.E. McCallum N. Parameswaran K.A. Perkins M.R. Picciotto M. Quik J.E. Rose A. Rothenfluh W.R. Schafer I.P. Stolerman R.F. Tyndale J.M. Wehner J.M. Zirger Guidelines on nicotine dose selection for in vivo research Psychopharmacology (Berlin) 190 3 2007 269 319
34. X. Meckler E. Bertandeau M.A. McNiven B. Allinquant A. Hemar The cytosolic domain of APP induces the relocalization of dynamin 3 in hippocampal neurons Eur. J. Neurosci. 24 9 2006 2439 2443
35. S. Mexal M. Frank R. Berger C.E. Adams R.G. Ross R. Freedman S. Leonard Differential modulation of gene expression in the NMDA postsynaptic density of schizophrenic and control smokers Brain Res Mol. Brain Res. 139 2 2005 317 332
36. A. Nordberg Mechanisms behind the neuroprotective actions of cholinesterase inhibitors in Alzheimer disease Alzheimer Dis. Assoc. Disord. 20 2 Suppl. 1 2006 S12 S18
37. A. Nordberg E. Hellstrom-Lindahl M. Lee M. Johnson M. Mousavi R. Hall E. Perry I. Bednar J. Court Chronic nicotine treatment reduces beta-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw) J. Neurochem. 81 3 2002 655 658
38. S. Oddo F.M. LaFerla The role of nicotinic acetylcholine receptors in Alzheimer's disease J. Physiol. Paris 99 2–3 2006 172 179
39. P. Pichat O.E. Bergis J.P. Terranova A. Urani C. Duarte V. Santucci C. Gueudet C. Voltz R. Steinberg J. Stemmelin F. Oury-Donat P. Avenet G. Griebel B. Scatton SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia Neuropsychopharmacology 32 1 2007 17 34
40. L.W. Role D.K. Berg Nicotinic receptors in the development and modulation of CNS synapses Neuron 16 6 1996 1077 1085
41. C. Sala K. Futai K. Yamamoto P.F. Worley Y. Hayashi M. Sheng Inhibition of dendritic spine morphogenesis and synaptic transmission by activity-inducible protein Homer1a J. Neurosci. 23 15 2003 6327 6337
42. D.J. Selkoe Alzheimer's disease is a synaptic failure Science 298 5594 2002 789 791
43. S.K. Smith H.A. Anderson G. Yu A.G. Robertson S.J. Allen S.J. Tyler R.L. Naylor G. Mason G.W. Wilcock P.A. Roche P.E. Fraser D. Dawbarn Identification of syntaxin 1A as a novel binding protein for presenilin-1 Brain Res. Mol. Brain Res. 78 1–2 2000 100 107
44. R.E. Tanzi The synaptic Abeta hypothesis of Alzheimer disease Nat. Neurosci. 8 8 2005 977 979
45. D.B. Timmermann J.H. Gronlien K.L. Kohlhaas E.O. Nielsen E. Dam T.D. Jorgensen P.K. Ahring D. Peters D. Holst J.K. Chrsitensen J. Malysz C.A. Briggs M. Gopalakrishnan G.M. Olsen An allosteric modulator of the alpha7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo J. Pharmacol. Exp. Ther. 323 1 2007 294 307
46. R.S. Turner Alzheimer's disease Semin. Neurol. 26 5 2006 499 506
47. T. Utsuki M. Shoaib H.W. Holloway D.K. Ingram W.C. Wallace V. Haroutunian K. Sambamurti D.K. Lahiri N.H. Greig Nicotine lowers the secretion of the Alzheimer's amyloid beta-protein precursor that contains amyloid beta-peptide in rat J. Alzheimers Dis. 4 5 2002 405 415
48. M. Van Kampen K. Selbach R. Schneider E. Schiegel F. Boess R. Schreiber AR-R 17779 improves social recognition in rats by activation of nicotinic alpha7 receptors Psychopharmacology (Berl) 172 4 2004 375 383
49. J.M. Wehner J.J. Keller A.B. Keller M.R. Picciotto R. Paylor T.K. Booker A. Beaudet S.F. Heinemann S.A. Balogh Role of neuronal nicotinic receptors in the effects of nicotine and ethanol on contextual fear conditioning Neuroscience 129 1 2004 11 24
50. D.G. Wishka D.P. Walker K.M. Yates S.C. Reitz S. Jia J.K. Myers K.L. Olson E.J. Jacobsen M.L. Wolfe V.E. Groppi A.J. Hanchar B.A. Thornburgh L.A. Cortes-Burgos E.H. Wong B.A. Staton T.J. Raub N.R. Higdon T.M. Wall R.S. Hurst R.R. Walters W.E. Hoffmann M. Hajos S. Franklin G. Carey L.H. Gold K.K. Cook S.B. Sands S.X. Zhao J.R. Soglia A.S. Kalgutkar S.P. Arneric B.N. Rogers Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure--activity relationship J. Med. Chem. 49 14 2006 4425 4436
51. Young, J.W., Crawford, N., Kelly, J.S., Kerr, L.E., Marston, H.M., Spratt, C., Finlayson, K., Sharkey, J., 2006. Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice. Eur. Neuropsychopharmacol.
52. D. Zhao J.B. Watson C.W. Xie Amyloid beta prevents activation of calcium/calmodulin-dependent protein kinase II and AMPA receptor phosphorylation during hippocampal long-term potentiation J. Neurophysiol. 92 5 2004 2853 2858